Table 3

Relative survival after 10 years for different subgroups

	Men				Women
Category	N	Death	Lost to follow-up	Relative survival (95% CI)	N	Death	Lost to follow-up	Relative survival (95% CI)	p Value*
Age<60	276	24	3	0.98 (0.94 to 1.01)	224	26	4	0.93 (0.87 to 0.96)	0.052
Age≥60 and<75	337	126	3	0.89 (0.81 to 0.96)	448	123	5	0.89 (0.84 to 0.95)	0.870
Age≥75	187	154	1	0.59 (0.42 to 0.80)	343	245	8	0.68 (0.56 to 0.79)	0.909
Diabetes duration<2 years	206	76	1	0.99 (0.92 to 1.06)	232	83	5	0.97 (0.90 to 1.03)	0.626
BMI<25	174	96	1	0.79 (0.66 to 0.92)	169	83	4	0.80 (0.67 to 0.91)	0.914
BMI 25–30	392	135	4	0.94 (0.87 to 1.01)	377	153	6	0.87 (0.79 to 0.94)	0.126
BMI>30	232	73	2	0.91 (0.83 to 0.99)	465	154	7	0.89 (0.83 to 0.94)	0.616
Non-smokers	583	226	5	0.93 (0.87 to 0.99)	869	349	14	0.86 (0.82 to 0.92)	0.121
Smokers	206	76	2	0.84 (0.75 to 0.92)	136	40	3	0.84 (0.73 to 0.92)	0.931
No history of CVD	492	132	3	0.99 (0.94 to 1.05)	717	228	11	0.92 (0.87 to 0.97)	0.046
History of CVD	306	172	4	0.73 (0.63 to 0.82)	298	166	6	0.70 (0.61 to 0.79)	0.648
Normoalbuminuria	450	116	3	1.00 (0.94 to 1.05)	655	198	11	0.95 (0.90 to 1.00)	0.214
Microalbuminuria	266	134	3	0.81 (0.71 to 0.90)	277	138	5	0.75 (0.66 to 0.84)	0.444
Macroalbuminuria	68	45	1	0.59 (0.40 to 0.78)	46	28	1	0.54 (0.34 to 0.73)	0.886
No microvascular complications	314	70	1	1.01 (0.95 to 1.07)	428	104	5	0.98 (0.93 to 1.03)	0.488
Microvascular complications†	464	227	5	0.82 (0.74 to 0.89)	546	263	10	0.77 (0.71 to 0.84)	0.395
Low-risk profile‡	154	21	1	1.08 (1.00 to 1.14)	270	58	4	1.01 (0.94 to 1.07)	0.106

*Difference between men and women.
†Defined as the presence of albuminuria, neuropathy or DRP.
‡Defined as non-smoking patients without a history of CVD and microvascular complications.
BMI, body mass index; CVD, cardiovascular disease; DRP, diabetic retinopathy.